2Ko J,Splitter GA.Molecular host-pathogen interaction in brucellosis:current understanding and future approaches to vaccine development for mice and humans[J].Clin Microbiol Rev,2003,16(1):65-78.
3Oliveira SC,Splitter GA.Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection[J].Vaccine,1996,14(10):959-962.
4Velikovsky CA,Goldbaum FA,Cassataro J,et al.Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544independently of the adjuvant formulation used[J].Infect Immun,2003,71(10):5750-5755.
5Velikovsky CA,Cassataro J,Giambartolomei GH,et al.A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice[J].Infect Immun,2002,70(5):2507-2511.
6Al-Mariri A,Tibor A,Mertens P,et al.Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant[J].Infect Immun,2001,69(8):4816-4822.
7Stabel TJ,Mayfield JE,Tabatabai LB,et al.Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus[J].Infect Immun,1990,58(7):2048-2055.
8Tibor A,Weynants V,Denoel P,et al.Molecular cloning,nucleotide sequence,and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins[J].Infect Immun,1994,62(9):3633-3639.
